Emergent Biosolutions Competitors and Similar CompaniesClear all

Emergent Biosolutions's competitors and similar companies include Valneva, LTS Lohmann Therapie-Systeme, Xoc Pharmaceuticals and Teva Pharmaceuticals.

	Emergent Biosolutions Emergent Biosolutions is a biopharmaceutical company that provides vaccines and therapeutics against public health threats.	Valneva Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.	LTS Lohmann Therapie-Systeme LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.	Xoc Pharmaceuticals Xoc Pharmaceuticals is a biopharmaceutical company focused on the development of innovative therapeutics.	Teva Pharmaceuticals Teva Pharmaceuticals is a global pharmaceutical company.
Founding Date	Founding Date 1998	Founding Date 2013	Founding Date 1984	Founding Date 2013	Founding Date 1901
Type	Type Public	Type Public	Type Subsidiary	Type Private	Type Public
Tags	Tags Healthcare drug development medtech pharma therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development medtech pharma therapy	Tags Healthcare drug development pharma therapy
Locations	Locations Gaithersburg, US HQ Mississauga, CA Winnipeg, CA Dublin, IE London, GB Canton, US Lansing, US see more	Locations Saint-Herblain, FR HQ Wien, AT Kirkland, CA Lyon, FR Solna, SE Fleet, GB Livingston, GB see more	Locations Andernach, DE HQ Shanghai, CN West Caldwell, US	Locations Los Gatos, US HQ	Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more
Employees	Employees 90044% decrease	Employees 713	Employees 2991% increase	Employees N/A	Employees 37,000
Valuation ($)	Valuation ($) 493.6 m	Valuation ($) 482.5 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 20.8 b
Financial
Revenue (est.)	Revenue (est.) $742.9m (FY, 2025)	Revenue (est.) €157.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $17.3b (FY, 2025)
Cost of goods	Cost of goods $326.2m (FY, 2025)	Cost of goods €8.2m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $8.3b (FY, 2025)
Gross profit	Gross profit $416.7m (FY, 2025)	Gross profit €177.7m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $8.9b (FY, 2025)
Net income	Net income $52.6m (FY, 2025)	Net income (€115.2m) (FY, 2025)	Net income N/A	Net income N/A	Net income $1.4b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 34.5m	Total funding raised $ 51.7m	Total funding raised N/A	Total funding raised $ 30m	Total funding raised $ 358m